Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

This study has been completed.
Sponsor:
Collaborator:
ID Biomedical Corporation, Quebec
Information provided by:
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01389479
First received: July 4, 2011
Last updated: July 6, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2005
  Primary Completion Date: May 2005 (Final data collection date for primary outcome measure)